References
- Pozen, Inc.Study Evaluating the Efficacy of PN 400 BID and Celebrex QD in Patients With Osteoarthritis of the Knee ClinicalTrialsgov [Internet]Bethesda (MD)National Library of Medicine (US)2000 -[2011 April 06]. Available from: http://clinicaltrials.gov/ct2/show/NCT00664560?term=NCT00664560&rank=1. Accessed 5 April 2011
- Pozen, Inc.Study Evaluating the Efficacy of PN 400 BID and Celecoxib QD in Patients With Osteoarthritis of the Knee ClinicalTrialsgov [Internet]Bethesda (MD)National Library of Medicine (US)2000 -[2011 April 06]. Available from: http://clinicaltrials.gov/ct2/show/NCT00665431. Accessed 5 April 2011.
- PincusTYaziciYBergmanMDevelopment of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical careClin Exp Rheumatol200523Suppl 39S19S2816273781
- SAS System for Windows [Computer program]Cary, NCSAS Institute Inc2010
- CronbachLJCoefficient alpha and the internal structure of testsPsychometrika195116297233
- ShroutPEFleissJLIntraclass correlations: Uses in assessing rater reliabilityPsychol Bull19798642042818839484
- GuyattGWalterSNormanGMeasuring change over time: assessing the usefulness of evaluative instrumentsJ Chronic Dis1987401711783818871
- US Food and Drug AdministrationGuidance for Industry Patient-Reported Outcome Measures: Use in Medicinal Product Development to Support Labeling ClaimsRockville, MDUS Department of Health and Human Services2009
- SloanJAAssessing the minimally clinically significant difference: Scientific considerations, challenges and solutionsCOPD20052576217136963
- RabeneckLCookKFWristersKSouchekJMenkeTWrayNPSODA (severity of dyspepsia assessment): A new effective outcome measure for dyspepsia-related healthJ Clin Epidemiol20015475576511470383
- RabeneckLWristersKGoldsteinJLEisenGDedhiyaSDBurkeTAReliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapyAm J Gastroenterol200297323911808967
- RabeneckLGoldsteinJLVuAMayneTJRubleeDAValdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritisAm J Gastroenterol20051001043105015842577
- StoneAAShiffmanSSchwartzJEBroderickJEHuffordMRPatient non-compliance with paper diariesBMJ20023241193119412016186
- BroderickJESchwartzJEVikingstadGPribbernowMGrossmanSStoneAAThe accuracy of pain and fatigue items across different reporting periodsPain200813914615718455312
- TalleyNJAmerican Gastroenterological Association medical position statement: Evaluation of dyspepsiaGastroenterology20051291753175516285970
- Veldhuyzen van ZantenSCan severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and helicobacter pylori associated gastritis?J Clin Epidemiol1993462732798455052
- Meineche-SchmidtVClassification of dyspepsia and response to treatment with proton-pump inhibitorsAliment Pharmacol Ther2004201171117915569120
- Meineche-SchmidtVEmpiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumptionAm J Gastroenterol2004991050105815180724